(Q36385912)

English

Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy

scientific article

Statements

Gemfibrozil and fenofibrate, Food and Drug Administration-approved lipid-lowering drugs, up-regulate tripeptidyl-peptidase 1 in brain cells via peroxisome proliferator-activated receptor α: implications for late infantile Batten disease therapy (English)
0 references
Arunava Ghosh
Grant T Corbett
Frank J Gonzalez
Kalipada Pahan
18 September 2012
287
38922-38935

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit